Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gulam Manji

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Oncologist|December 14, 2024
Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancerKarie Runcie, Yadriel Bracero, Avishai Samouha, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
STDP-inspired temporal transition modeling for adaptive clinical risk prediction from electronic health recordsLiyuan Gong, Nitish Aswani, Peter Shahinnian, et al.
Future Oncology (London, England)|October 10, 2023
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR <i>BRAF</i>V600E-mutant mCRCElena Elez, Scott Kopetz, Josep Tabernero, et al.
Journal of Oncology|March 10, 2020
Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line SettingBrianna Lauren, Sassan Ostvar, Elisabeth Silver, et al.
The Oncologist|May 31, 2025
A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgeryRuth A White, Valeria Mezzano-Robinson, Qiongyu Shi, et al.
Surgical Endoscopy|June 2, 2026
EUS-guided drainage of symptomatic postoperative fluid collections: a retrospective cohort study evaluating timing of intervention and clinical outcomesMuhammad H Raza, Jonathan R Tiao, Catherine K Wang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Oncologist|December 14, 2024
Phase I study of intratumoral injection of talimogene laherparepvec for the treatment of advanced pancreatic cancerKarie Runcie, Yadriel Bracero, Avishai Samouha, et al.
Medrxiv : the Preprint Server for Health Sciences|June 22, 2026
STDP-inspired temporal transition modeling for adaptive clinical risk prediction from electronic health recordsLiyuan Gong, Nitish Aswani, Peter Shahinnian, et al.
Future Oncology (London, England)|October 10, 2023
SEAMARK: phase II study of first-line encorafenib and cetuximab plus pembrolizumab for MSI-H/dMMR <i>BRAF</i>V600E-mutant mCRCElena Elez, Scott Kopetz, Josep Tabernero, et al.
Journal of Oncology|March 10, 2020
Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line SettingBrianna Lauren, Sassan Ostvar, Elisabeth Silver, et al.
The Oncologist|May 31, 2025
A phase 0, window of opportunity study of parasympathetic stimulation with bethanechol in localized pancreatic adenocarcinoma prior to surgeryRuth A White, Valeria Mezzano-Robinson, Qiongyu Shi, et al.
Surgical Endoscopy|June 2, 2026
EUS-guided drainage of symptomatic postoperative fluid collections: a retrospective cohort study evaluating timing of intervention and clinical outcomesMuhammad H Raza, Jonathan R Tiao, Catherine K Wang, et al.
Pageof 1